首页 › 基金 › Ally Bridge Group (NY) LLC › AVTX
Ally Bridge Group (NY) LLC 对 AVTX 的持仓历史
AVALO THERAPEUTICS INC · 医疗保健
Ally Bridge Group (NY) LLC 在 Q3 2026 的 13F 申报中披露持有 AVTX(AVALO THERAPEUTICS INC)134,429 股,市值约 US$2.1M,约占其申报组合的 2.74%,在其申报持仓中市值排名第 13 位。 Ally Bridge Group (NY) LLC 最近 5 个申报季度中有 3 个季度披露了 AVTX 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Ally Bridge Group (NY) LLC 对 AVTX 的持仓演变
Ally Bridge Group (NY) LLC 于 Q3 2025 首次披露 AVTX 持仓:178,100 股(约 US$2.3M)。 该持仓在 Q2 2026 达到峰值 150,000 股,市值约 US$2.8M。 在 3 次申报中,Ally Bridge Group (NY) LLC 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 134,429 股、市值约 US$2.1M,环比减持 -15,571 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 178.10K | $2.26M | 新进 |
| Q2 2026 | 150.00K | $2.77M | 新进 |
| Q3 2026 | 134.43K | $2.06M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AVTX 与 13F 数据
AVTX(AVALO THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 68 只申报持有 AVTX,申报仓位最大的包括:FARALLON CAPITAL MANAGEMENT, L.L.C. (US$60.9M), Deep Track Capital, LP (US$55.3M), Caligan Partners LP (US$50.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AVTX 的基金
- FARALLON CAPITAL MANAGEMENT, L.L.C. 3.97M 股 · $60.92M · Q3 2026
- Deep Track Capital, LP 3.61M 股 · $55.34M · Q3 2026
- Caligan Partners LP 3.27M 股 · $50.10M · Q3 2026
- Affinity Asset Advisors, LLC 3.24M 股 · $49.74M · Q3 2026
- TCG Crossover Management, LLC 3.02M 股 · $46.25M · Q3 2026
- 法拉龙资本管理 2.50M 股 · $46.16M · Q2 2026
- Avoro Capital Advisors LLC 2.38M 股 · $36.45M · Q3 2026
- Nantahala Capital Management, LLC 2.14M 股 · $32.84M · Q3 2026
- BRAIDWELL LP 1.61M 股 · $24.67M · Q3 2026
- Logos Global Management LP 1.50M 股 · $23.00M · Q3 2026
- Trails Edge Capital Partners, LP 1.50M 股 · $23.00M · Q3 2026
- Commodore Capital LP 1.02M 股 · $15.61M · Q3 2026
更多关于 Ally Bridge Group (NY) LLC
常见问题
How long has Ally Bridge Group (NY) LLC held AVTX?
Ally Bridge Group (NY) LLC has disclosed AVTX holdings in 3 of the last 5 reported quarters, going back to Q3 2025.
What is Ally Bridge Group (NY) LLC's current position in AVTX?
As of Q3 2026, Ally Bridge Group (NY) LLC holds 134.43K shares of AVTX (AVALO THERAPEUTICS INC), valued at $2.06M, representing 2.74% of its reported portfolio and ranking #13.
Has Ally Bridge Group (NY) LLC been buying or selling AVTX?
In the latest 13F filing (Q3 2026), Ally Bridge Group (NY) LLC reduced its position in AVTX. The position peaked in Q2 2026 at 150.00K shares.
Which other funds hold AVTX?
Other major institutional holders of AVTX include FARALLON CAPITAL MANAGEMENT, L.L.C., Deep Track Capital, LP, Caligan Partners LP, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.